Trial Profile
A safety and efficacy trial of cabazitaxel and prednisolone for the treatment of metastatic castration‑resistant prostatic carcinoma in Korean patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary) ; Prednisolone
- Indications Prostate cancer
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Sponsors Sanofi
- 09 Dec 2015 New trial record